Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn’s disease-Reference-Cited by-同舟云学术

Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn’s disease

Published:2019-02 Issue:2 Volume:89 Page:364-372
ISSN:0016-5107
Container-title:Gastrointestinal Endoscopy
language:en
Short-container-title:Gastrointestinal Endoscopy

Author:

Carman Nicholas,Tomalty Diane,Church Peter C.,Mack David R.,Benchimol Eric I.,Otley Anthony R.,Jacobson Kevan,Huynh Hien Q.,DeBruyn Jennifer C.,El-Matary Wael,Sherlock Mary,Van Limbergen Johan,Griffiths Anne M.,Walters Thomas D.

Publisher

Elsevier BV

Subject

Gastroenterology,Radiology, Nuclear Medicine and imaging

Reference23 articles.

1. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives;Cellier;Gut,1994

2. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice;Levesque;Gastroenterology,2015

3. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD;Daperno;Gastrointest Endosc,2004

4. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends;Benchimol;Inflamm Bowel Dis,2014

5. Natural history of Crohn's disease: comparison between childhood- and adult-onset disease;Pigneur;Inflamm Bowel Dis,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn’s disease;The American Journal of Clinical Nutrition;2024-04

2. Operating Properties of Disease Activity Indices in Pediatric Inflammatory Bowel Disease: A Systematic Review;Inflammatory Bowel Diseases;2024-03-28

3. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease;Gastroenterology;2023-12

4. Natural History of Pediatric Patients With Crohn’s Disease Treated With Mesalamine Therapy;JPGN Reports;2023-11

5. A comparison of the Child Health Utility 9D and the Health Utilities Index for estimating health utilities in pediatric inflammatory bowel disease;Quality of Life Research;2023-04-01